hydroxyproline has been researched along with oxaceprol in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (16.00) | 18.7374 |
1990's | 8 (32.00) | 18.2507 |
2000's | 6 (24.00) | 29.6817 |
2010's | 5 (20.00) | 24.3611 |
2020's | 2 (8.00) | 2.80 |
Authors | Studies |
---|---|
Cuzzocrea, D; Famulari, C; Monaco, M; Perri, S; Terranova, ML; Versaci, A | 1 |
Aprile, F; Mitrovic, D; Riera, H | 1 |
Kusche, W; Lachmann, G; Siegemund, B | 1 |
Crespo, V; Delgado, ML; Fajardo, FS; Ocaña, J; Pastor, R; Pérez de Vargas, I; Wilhelmi, ML | 1 |
Cetta, G; Manganoni, AM; Pancera, C; Pasolini, G; Zanaboni, G | 1 |
Charpentier, C; Dagbovie, K; Johnstone, RA; Larregue, M; Lemonnier, A | 1 |
Brune, K; Ionac, M; Parnham, MJ; Plauchithiu, M | 1 |
Harris, A; Messmer, K; Schropp, A | 1 |
Bouvenot, G; Villani, P | 1 |
Bauer, HW; Gimbel, W; Henke, HD; Klasser, M; Rolinger, H; Schladitz, G; Steinbach, K; von Hanstein, KL | 1 |
Parnham, MJ | 1 |
Dirschedl, H; Fürst, M; Gimbel, W; Herrmann, G; Hildebrandt, HD; Jungmichel, D; Klasser, M; Parnham, MJ; Rohde, H; Steeger, D; Venbrocks, R; Wirbitzky, J | 1 |
Hofbauer, A; Messmer, K; Refior, HJ; Veihelmann, A | 1 |
Lasek, R; Victor, N; Witte, S | 1 |
Harris, AG; Messmer, K; Schropp, A | 1 |
Hatton, GI; Ponzio, TA | 1 |
Clayton, JJ | 1 |
Aliev, AE; Bhandal, S; Courtier-Murias, D | 1 |
Chen, N; Ding, G; Gu, J; Zhang, Z | 1 |
Hibi, T; Hoa, BT; Matsuo, G; Nasuno, R; Sasano, Y; Takagi, H | 1 |
Bach, TM; Hara, R; Kino, K; Ohtsu, I; Takagi, H; Yoshida, N | 1 |
Francis, NK; Hota, T; Mitra, A; Pawar, HS; Peter, N | 1 |
Bhate, J; Durg, S; Lobo, M; Rao, G; Venkatachalam, L | 1 |
Alarçin, E; Bal-Ozturk, A; Demirbağ, Ç; Karsli-Ceppioglu, S; Kerimoğlu, O | 1 |
Naru, E; Obata, Y; Ogura, T; Ohnari, H; Sakata, O; Sekiya, M | 1 |
5 review(s) available for hydroxyproline and oxaceprol
Article | Year |
---|---|
[Assessment of the placebo effect of symptomatic slow-acting anti-arthritics].
Topics: Activities of Daily Living; Aged; Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Chondroitin Sulfates; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteoarthritis; Pain; Pain Measurement; Placebo Effect; Randomized Controlled Trials as Topic; Research Design; Time Factors; Treatment Outcome | 1998 |
Antirheumatic agents and leukocyte recruitment. New light on the mechanism of action of oxaceprol.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Cell Adhesion; Clinical Trials as Topic; Humans; Hydroxyproline; Joint Diseases; Leukocytes | 1999 |
[Meta-analysis of the efficacy of adenosylmethionine and oxaceprol in the treatment of osteoarthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Confidence Intervals; Data Interpretation, Statistical; Diclofenac; Humans; Hydroxyproline; Ibuprofen; Osteoarthritis; Placebos; Randomized Controlled Trials as Topic; S-Adenosylmethionine; Therapeutic Equivalency | 2002 |
Nutraceuticals in the management of osteoarthritis.
Topics: Aged; Amino Acids, Sulfur; Anthraquinones; Boswellia; Chondroitin; Dietary Supplements; Gelatin; Glucosamine; Humans; Hydroxyproline; Osteoarthritis; Persea; Phytotherapy; Plant Oils; Protein Hydrolysates; S-Adenosylmethionine; Soybean Oil | 2007 |
A systematic review and meta-analysis of oxaceprol in the management of osteoarthritis: An evidence from randomized parallel-group controlled trials.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Diclofenac; Humans; Hydroxyproline; Ibuprofen; Osteoarthritis; Randomized Controlled Trials as Topic; Sample Size | 2019 |
2 trial(s) available for hydroxyproline and oxaceprol
Article | Year |
---|---|
Oxaceprol is as effective as diclofenac in the therapy of osteoarthritis of the knee and hip.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Diclofenac; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydroxyproline; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain Measurement; Range of Motion, Articular; Safety; Treatment Outcome | 1999 |
Oxaceprol is a well-tolerated therapy for osteoarthritis with efficacy equivalent to diclofenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Diclofenac; Double-Blind Method; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain Measurement; Safety; Therapeutic Equivalency; Weight-Bearing | 2000 |
18 other study(ies) available for hydroxyproline and oxaceprol
Article | Year |
---|---|
[Action of N-acetyl-hydroxyproline in the treatment of cutaneous ulcerative lesions].
Topics: Adult; Aged; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteomyelitis; Phlebitis; Pressure Ulcer; Skin Ulcer; Ulcer; Varicose Ulcer | 1979 |
[Effect of oxaceprol on the structure of proteoglycans synthesized by articular chondrocytes from calves].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cartilage, Articular; Cattle; Chromatography, Gel; Electrophoresis, Cellulose Acetate; Hydroxyproline; In Vitro Techniques; Proteoglycans | 1991 |
Pharmacokinetics and metabolism of 14C-oxaceprol in beagle dogs after intramuscular and oral administration.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dogs; Feces; Hydroxyproline; Injections, Intramuscular; Male; Synovial Fluid | 1990 |
[Sclerodermiform porphyria cutanea tarda. Ultrastructural study].
Topics: Aged; Animals; Bicarbonates; Cricetinae; Diabetes Complications; Diagnosis, Differential; Hemorrhage; Humans; Hydroxyproline; Inflammation; Male; Middle Aged; Porphyrias; Scleroderma, Systemic; Skin; Skin Diseases; Sodium; Sodium Bicarbonate | 1985 |
[Leg ulcers caused by prolidase deficiency].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dipeptidases; Humans; Hydroxyproline; Leg Ulcer; Male; Phenytoin | 1988 |
Prolidase deficiency with iminodipeptiduria: biochemical investigations and first results of attempted therapy.
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Ascorbic Acid; Dipeptidases; Dipeptides; Erythrocytes; Female; Humans; Hydroxyproline; Manganese; Phenytoin; Proline | 1981 |
Oxaceprol, an atypical inhibitor of inflammation and joint damage.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Dinoprostone; Edema; Eicosanoids; Granuloma; Hydroxyproline; Hyperalgesia; Indomethacin; Joints; Leukotriene C4; Macrophages, Peritoneal; Male; Mice; Rats; Rats, Sprague-Dawley | 1996 |
Effects of oxaceprol on the microcirculation in ischemia/reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cell Adhesion; Cricetinae; Dextrans; Disease Models, Animal; Fluorescein-5-isothiocyanate; Hydroxyproline; Leukocytes; Mesocricetus; Microcirculation; Muscle, Skeletal; Reperfusion Injury; Skin | 1998 |
Oxaceprol, an atypical inhibitor of inflammation, reduces leukocyte adherence in mouse antigen-induced arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens; Arthritis; Cell Adhesion; Disease Models, Animal; Female; Hydroxyproline; Leukocytes; Mice; Mice, Inbred BALB C; Microcirculation; Synovial Membrane | 2001 |
[Oxaceprol reduced leukocyte adhesion and extravasation and preserves perfusion of tissue after ischemia/reperfusion].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Cell Adhesion; Cricetinae; Hydroxyproline; Leukocyte Count; Leukocytes; Mesocricetus; Microcirculation; Microscopy, Fluorescence; Muscle, Skeletal; Reperfusion Injury; Skin Window Technique | 1998 |
Adenosine postsynaptically modulates supraoptic neuronal excitability.
Topics: Adenosine; Analgesics; Animals; Calcium; Dose-Response Relationship, Drug; Drug Interactions; Hydroxyproline; Immunohistochemistry; In Vitro Techniques; Male; Membrane Potentials; Neural Inhibition; Neurons; Patch-Clamp Techniques; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Supraoptic Nucleus; Synapses; Synaptic Transmission; Xanthines | 2005 |
Quantum mechanical and NMR studies of ring puckering and cis/trans-rotameric interconversion in prolines and hydroxyprolines.
Topics: Hydroxyproline; Magnetic Resonance Spectroscopy; Models, Chemical; Models, Molecular; Peptides, Cyclic; Phase Transition; Proline; Protein Conformation; Quantum Theory; Stereoisomerism | 2009 |
Determination of oxaceprol in rat plasma by LC-MS/MS and its application in a pharmacokinetic study.
Topics: Acetates; Acetonitriles; Administration, Oral; Animals; Chemistry Techniques, Analytical; Chromatography, Liquid; Hydroxyproline; Ions; Mass Spectrometry; Methanol; Models, Chemical; Quality Control; Rats; Reproducibility of Results; Sensitivity and Specificity | 2011 |
Production of N-acetyl cis-4-hydroxy-L-proline by the yeast N-acetyltransferase Mpr1.
Topics: Acetylation; Acetyltransferases; Biotechnology; Escherichia coli; Hydroxyproline; Prodrugs; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins | 2012 |
Microbial production of N-acetyl cis-4-hydroxy-L-proline by coexpression of the Rhizobium L-proline cis-4-hydroxylase and the yeast N-acetyltransferase Mpr1.
Topics: Acetyltransferases; Chromatography, High Pressure Liquid; Cloning, Molecular; Culture Media; Escherichia coli; Genetic Engineering; Hydroxyproline; Plasmids; Procollagen-Proline Dioxygenase; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sinorhizobium meliloti | 2013 |
Comparative evaluation of therapeutic efficacy of intra-articular oxaceprol with conventional modalities in osteoarthritis animal model.
Topics: Animals; Antirheumatic Agents; Arthralgia; Cartilage, Articular; Disease Models, Animal; Hydroxyproline; Injections, Intra-Articular; Knee Joint; Male; Osteoarthritis, Knee; Pain Measurement; Rabbits; Random Allocation; Therapeutic Equivalency | 2018 |
Development and characterization of oxaceprol-loaded poly-lactide-co-glycolide nanoparticles for the treatment of osteoarthritis.
Topics: Antirheumatic Agents; Cells, Cultured; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Humans; Hydroxyproline; Nanoparticles; Osteoarthritis; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer | 2020 |
Amino Acids and Their N-Acetylated Derivatives Maintain the Skin's Barrier Function.
Topics: Acetylation; Amino Acids; Calorimetry, Differential Scanning; Cholesterol; Epidermis; Humans; Hydroxyproline; Lipid Bilayers; Nanostructures; Palmitic Acid; Scattering, Small Angle; Skin Absorption; X-Ray Diffraction | 2021 |